Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
466.71
+39.09 (9.14%)
At close: Jul 23, 2025, 4:00 PM
467.51
+0.80 (0.17%)
After-hours: Jul 23, 2025, 6:45 PM EDT
Thermo Fisher Revenue
Thermo Fisher had revenue of $10.86B in the quarter ending June 28, 2025, with 2.98% growth. This brings the company's revenue in the last twelve months to $43.21B, up 2.05% year-over-year. In the year 2024, Thermo Fisher had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$43.21B
Revenue Growth
+2.05%
P/S Ratio
3.76
Revenue / Employee
$345,696
Employees
125,000
Market Cap
176.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| Novartis AG | 55.19B |
| AstraZeneca | 54.98B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
TMO News
- 6 hours ago - Why Thermo Fisher Stock Is Rising Wednesday - Benzinga
- 6 hours ago - Thermo Fisher Scientific Stock Jumps on Strong Results, Higher Outlook - Investopedia
- 8 hours ago - Thermo Fisher Scientific Inc. (TMO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 10 hours ago - Thermo Fisher Scientific's Chief Financial Officer, Stephen Williamson, to Retire in Early 2026 - Business Wire
- 12 hours ago - Thermo Fisher beats quarterly estimates on resilient demand for its tools and services - Reuters
- 13 hours ago - Thermo Fisher Scientific Reports Second Quarter 2025 Results - Business Wire
- 1 day ago - Thermo Fisher Scientific Company Analysis Report | Key Milestones/History, Product Offerings, Technologies, Major Applications and End-user Industries - GlobeNewsWire
- 7 days ago - Thermo Fisher acquires Sanofi's New Jersey manufacturing site - Reuters